Therapeutic Area | MeSH |
---|---|
immune system diseases | D007154 |
Code | Description |
---|---|
J7505 | Muromonab-cd3, parenteral, 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 2 | — | 1 | 3 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | 2 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | — | 2 | — | — | — | 2 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | 1 | — | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 1 | — | — | — | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | 1 | — | — | — | 1 |
Mantle-cell lymphoma | D020522 | — | C83.1 | — | 1 | — | — | — | 1 |
Follicular lymphoma | D008224 | — | C82 | — | 1 | — | — | — | 1 |
Drug common name | Muromonab-cd3 |
INN | muromonab-cd3 |
Description | Muromonab-CD3 (mouse mab) |
Classification | Antibody |
Drug class | cannabinol derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201608 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00075 |
UNII ID | JGA39ICE2V (ChemIDplus, GSRS) |